Search for association between suicide attempt and serotonergic polymorphisms

Psychiatric Genetics

Volumn 10, Issue 1, 2000, Pages 19-26

  Geijer, T ^a,f   Frisch, A ^b   Perssona, M L ^a,c   Wasserman, D ^a   Rockah, R ^b   Michaelovsky, E ^b   Apter, A ^d   Jonsson E G ^c   Nothen M M ^e   Weizman, A ^d  

^a Swedish Natl/Stockholm County Cncl   (Sweden)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAROLINSKA INSTITUTE   (Sweden)

^d GEHA MENTAL HEALTH CENTER   (Israel)

^e UNIVERSITY OF BONN   (Germany)

^f National Centre for Suicide Research   (Sweden)

Author keywords

Adjustment disorders; Association study; Attempted suicide; Genetics; Personality disorders; Serotonin; Substance use disorders; Unipolar disorders

Indexed keywords

SEROTONIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; NEUROTRANSMISSION; PERSONALITY DISORDER; PHENOTYPE; PRIORITY JOURNAL; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; SUICIDE;

EID: 0034042297     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200010010-00004     Document Type: Article

References (60)

1. Abbar M, Courtet P, Amadéo S, Caer Y, Mallet J, Baldy-Moulinier M et al. (1995). Suicidal behaviors and the tryptophan hydroxylase gene. Arch Gen Psychiatry 52:846-849.
2. American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders, revised. 3rd ed. Washington, DC: American Psychiatric Association.
3. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, DSM-IV. 4th ed. Washington, DC: American Psychiatric Association.
4. Arango V, Ernsberger P, Marzuk PM, Chen J-S, Tierney K, Stanley M et al. (1990). Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047.
5. Arango V, Underwood MD, Mann JJ (1992). Alterations in monoamine receptors in the brain of suicide victims. J Clin Psychopharmacol 12(2 suppl):8S-12S.
6. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J et al. (1995). Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346:281-282.
7. Arranz MJ, Erdmann J, Kirov G, Rietschel M, Sodhi M, Albus M et al. (1997). 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Neurosci Lett 224:95-98.
8. Åsberg M, Nordström P, Träskman-Bendz L (1986). Cerebrospinal fluid studies in suicide. An overview. Ann NY Acad Sci 487:243-255.
9. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD (1997). Effects of selective serotonin inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 41:184-190.
10. Ball D, Hill L, Freeman B, Eley TC, Strelau J, Riemann R et al. (1997). The serotonin transporter gene and peer-rated neuroticism. Neuroreport 8:1301-1304.
11. Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D et al. (1998). Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 55:33-37.
12. Berretini WH, Nurnberger JI, Narrow W (1986). Cerebrospinal fluid studies of bipolar patients with and without a history of suicide attempt. Ann NY Acad Sci 487:197-201.
13. Brent DA, Bridge J, Johnson BA, Connolly J (1996). Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 53:1145-1152.
14. Buresi C, Courtet P, Leboyer M, Feingold J, Malafosse A (1997). Association between suicide attempt and the tryptophan hydroxylase (TPH) gene [Abstract]. Am J Hum Genet 61(suppl):A270.
15. Coccaro EF, Berman ME, Kavoussi RJ, Hauger RL (1996). Relationship of prolactin response to D-fenfluramine and behavioral questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 40:157-164.
16. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D et al. (1996). A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453-460.
17. Decken J, Catalano M, Heils A, Di Bella D, Friess F, Politi E et al. (1997). Functional promoter polymorphism of the human transporter: lack of association with panic disorder. Psychiatr Genet 7:45-47.
18. De Vane CL (1997). The place of selective serotonin reuptake inhibitors in the treatment of panic disorder. Pharmacotherapy 17:282-292.
19. Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre YD et al. (1999). Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 46:196-201.
20. Erdfelder E, Faul F, Buchner A (1996). GPower: a general power analysis program. Behav Res Methods Instrum Comput 28:1-11.
21. Erdmann J, Shimron-Abarbanell D, Rietschel M, Albus M, Maier W, Körner J et al. (1996). Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97:614-619.
22. Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC (1998). No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behavior in major affective disorder. Am J Med Genet 81:245-247.
23. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G et al. (1994). Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26-32.
24. Gutiérrez B, Arranz M, Fananás L, Vallès V, Guillamat R, van Os J, Collier D (1995). 5HT2A receptor gene bipolar affective disorder [Letter]. Lancet 346:969.
25. He L, Li T, Melville C, Liu S, Feng G-Y, Gu N-F et al. (1999). 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am J Med Genet 88:95-98.
26. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
27. Higley JD, Linnoila M (1997). A nonhuman primate model of excessive alcohol intake. Personality and neurobiological parallels of type I-and type II-like alcoholism. Recent Dev Alcoholism 13:191-219.
28. Higley JD, Suomi SJ, Linnoila M (1996). A nonhuman primate model of type II alcoholism? Part 2. Diminished social competence and excessive aggression correlates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Alcoholism: Clin Exp Res 20:643-650.
29. Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomura Y, Kono Y et al. (1996). Positive association between a DNA sequence variant in the serotonin 2A receptor gene with schizophrenia. Am J Med Genet 67:103-105.
30. Jönsson E, Nöthen M, Bunzel R, Propping P, Sedvall G (1996). 5HT2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 347:1831.
31. Kirov G, Owen MJ, Jones I, McCandless F, Craddock N (1999). Tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 56:98-99.
32. Kunugi H, Tatsumi M, Sakai T, Hattori M, Nanko S (1996). Serotonin transporter gene polymorphism and affective disorder [Letter]. Lancet 347:1340.
33. Kunugi H, Tatsumi M, Sakai T, Hattori M, Nanko S (1999). No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 156:774-776.
34. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
35. Mann JJ, Arango V (1992). Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 12:2S-7S.
36. Mann JJ, Malone KM (1997). Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 41:162-171.
37. Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J (1997). Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 154:1451-1453.
38. McQuillin A, Lawrence J, Kalsi G, Chen A, Gurling H, Curtis D (1999). No allelic association between bipolar affective disorder and the tryptophan hydroxylase gene. Arch Gen Psychiatry 56:99-100.
39. Moller SE, Mortensen EL, Breum L, Ailing C, Larsen OG, Boge-Rasmussen T et al. (1996). Aggression and personality: association with amino acids and monoamine metabolites. Psychol Med 26:323-331.
40. Muck-Seler D, Jakovljevic M, Pivac N (1996). Platelet 5-HT concentrations and suicidal behavior in recurrent major depression. J Affect Disorders 39:73-80.
41. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M (1994). Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 51:34-38.
42. Nielsen DA, Jenkins GL, Stefanisko KM, Jefferson KK, Goldman D (1997). Sequence, splice sites and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Mol Brain Res 45:145-148.
43. Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC et al. (1998). A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 55:593-602.
44. Nimgaonkar VL, Zhang XR, Brar JS, DeLeo M, Ganguli R (1996). 5-HT2 receptor gene locus: association with schizophrenia or treatment response not detected. Psychiatr Genet 6:23-27.
45. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar J, Goodwin GN, Smith CAD (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347:731-732.
46. Roy A (1983). Family history of suicide. Arch Gen Psychiatry 40:971-974.
47. Roy A (1993). Genetic and biologic risk factors for suicide in depressive disorders. Psychiatr Q 64:345-358.
48. Schatzberg AF (1996-1997). Treatment of severe depression with the selective serotonin reuptake inhibitors. Depression Anxiety 4:182-189.
49. Schmidtke A, Bille-Brahe U, Kerkhof A, Bjerke T, Crepet P, Haring C et al. (1996). Attempted suicide in Europe: rates, trends and sociodemographic characteristics of suicide attempters during the period 1989-1992. Results of the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatr Scand 93:327-338.
50. Schulsinger F, Kety S, Rosenthal D, Wender P (1979). A family study of suicide. In: Origins, prevention and treatment of affective disorders, Schou M, Stromgren E (eds). New York: Academic Press. pp. 277-287.
51. Secunda S, Cross C, Koslow S, Katz M, Kocsis J, Maas J, Landis H (1986). Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry 21:756-767.
52. Sheehan DV, Harnett-Sheehan K (1996). The role of SSRI in panic disorder. J Clin Psychiatry 57(suppl 10):51-58.
53. Spitzer RL, Williams JBW, Gibbon M (1989). Instruction manual for Structured Clinical Interview for DSM-III-R, SCID-5/1/89 revision. New York: New York State Psychiatric Institute, Biometrics Research.
54. Stöber G, Heils A, Lesch KP (1996). Serotonin transporter gene polymorphism and affective disorder. Lancet 347:1340-1341.
55. Van der Kolk BA, Perry JC, Herman JL (1991). Childhood origins of self-destructive behavior. Am J Psychiatry 148:1665-1671.
56. Verga M, Macciardi F, Cohen S, Pedrini S, Smeraldi E (1997). No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am J Med Genet 74:21-25.
57. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK (1993). An Mspl polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet 2:338.
58. Wender P, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I (1986). Psychiatric disorders in biological and adoptives families of adopted individuals with affective disorders. Arch Gen Psychiatry 43:923-929.
59. Williams J, Spulock G, McGuffin P, Mallet J, Nöthen MM, Aschauer H et al. (1996). Association between schizophrenia and T102C polymorphism of the 5 hydroxytryptamine type 2a-receptor. Lancet 347: 1294-1296.
60. Williams J, McGuffin P, Nöthen MM, Owen MJ (1997). Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia [Letter]. Lancet 349:1221.